Stocktoria
MARIMED INC. MRMD
OTC · OOTC · stock
MARIMED INC. (MRMD) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $159.8M at a -9.1% net margin.
4/9
Piotroski F — financial health
-1.76
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Net margin-9.1%
Return on equity-29%
Revenue trend · last 10y · up
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.001 |
| Retained earnings / assets | -0.632 |
| EBIT / assets | -0.014 |
| Equity / liabilities | 0.363 |
FAQ
Is MRMD financially healthy?
MARIMED INC.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does MRMD pay a dividend?
No, MARIMED INC. does not currently pay a dividend.
How profitable is MRMD?
In FY2025, MARIMED INC. had a net margin of -9.1% and a return on equity of -29.0%.
Source: SEC EDGAR filings · CIK 0001522767 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.